View original post here: Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corporate Update
View original post here: Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corporate Update
The rest is here: Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
Read more here: Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research
Visit link: CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update
Follow this link: Panavance Therapeutics Announces Foundational Publication of Misetionamide (GP-2250) in Ovarian Cancer in the Journal, Cancer Medicine
Go here to see the original: Verrica Pharmaceuticals Announces Positive Preliminary Topline Results from Part 2 of Phase 2 Clinical Study of VP-315, an Investigational Oncolytic...
Read more from the original source: Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors
Originally posted here: Veralox Therapeutics Announces EMA Orphan Drug Designation for VLX-1005
Read this article: Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results
Read more: Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Recent Comments